Someone with a lot of money to spend has taken a bullish stance on Gilead Sciences GILD.
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with GILD, it often means somebody knows something is about to happen.
So how do we know what this whale just did?
Today, Benzinga's options scanner spotted 14 uncommon options trades for Gilead Sciences.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 50%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $727,842, and 8 are calls, for a total amount of $472,590.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $90.0 for Gilead Sciences over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Gilead Sciences's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Gilead Sciences's whale activity within a strike price range from $65.0 to $90.0 in the last 30 days.
Gilead Sciences Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
|Symbol||PUT/CALL||Trade Type||Sentiment||Exp. Date||Strike Price||Total Trade Price||Open Interest||Volume|
Where Is Gilead Sciences Standing Right Now?
- With a volume of 6,178,282, the price of GILD is down -3.84% at $76.78.
- RSI indicators hint that the underlying stock may be oversold.
- Next earnings are expected to be released in 41 days.
What The Experts Say On Gilead Sciences:
- RBC Capital has decided to maintain their Sector Perform rating on Gilead Sciences, which currently sits at a price target of $86.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Gilead Sciences, Benzinga Pro gives you real-time options trades alerts.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.